I hope Eath comes back on to explain to you all the significance of the trial.
It's all to do about
1/where this trial sits in the overall development of a potential vaccine and
2/ the statistical significance of the results (it's power was small because of the small number of participants) .. but that has to do with point 1/)
and
3/ the costs of taking it further.
Listen to what he says about it OK?
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
AVR
anteris technologies global corp.
Add to My Watchlist
1.83%
!
$8.34

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-147
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.34 |
Change
0.150(1.83%) |
Mkt cap ! $119.8M |
Open | High | Low | Value | Volume |
$8.19 | $8.34 | $8.10 | $23.15K | 2.839K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 690 | $8.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.34 | 126 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 690 | 8.120 |
1 | 225 | 8.110 |
2 | 3374 | 7.810 |
1 | 1000 | 7.800 |
1 | 220 | 7.750 |
Price($) | Vol. | No. |
---|---|---|
8.340 | 126 | 1 |
8.350 | 1000 | 1 |
8.400 | 5632 | 2 |
8.450 | 720 | 1 |
8.490 | 1368 | 1 |
Last trade - 11.06am 18/09/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |